Recent Quotes (30 days)

You have no recent quotes
chg | %

ProMetic Life Sciences Inc.  

(Public, TSE:PLI)   Watch this stock  
Find more results for PLI
1.92
-0.03 (-1.54%)
Delayed:   10:57AM EDT
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.90 - 1.96
52 week 1.40 - 2.87
Open 1.96
Vol / Avg. 434,274.00/1.36M
Mkt cap 1.11B
P/E     -
Div/yield     -
EPS -0.08
Shares 580.72M
Beta 1.11
Inst. own     -
Nov 11, 2015
Q3 2015 ProMetic Life Sciences Inc Earnings Release (Estimated) Add to calendar
Aug 14, 2015
Q2 2015 ProMetic Life Sciences Inc Earnings Call - Webcast
Aug 13, 2015
ProMetic Life Sciences Inc at Canaccord Genuity Growth Conference
Aug 13, 2015
Q2 2015 ProMetic Life Sciences Inc Earnings Release
  

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -466.60% 11.20%
Operating margin -565.11% -73.16%
EBITD margin - -132.19%
Return on average assets -25.20% 2.03%
Return on average equity -51.09% 13.15%
Employees 197 -
CDP Score - -

Address

440 Boul. Armand-Frappier, Suite 300
LAVAL, QC H7V 4B4
Canada
+1-450-7810115 (Phone)
+1-450-7814477 (Fax)

Website links

Description

ProMetic Life Sciences Inc. (ProMetic) is a Canada-based biopharmaceutical company. The Company offers solutions in bioseparations, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens. The Company operates through two segments: Therapeutics and Protein Technology. Therapeutics segment is a small molecule drug discovery business. It has lead compounds, namely PBI-4050 indicated for the treatment of fibrosis in patients with chronic kidney diseases and certain cancers, and the side effects associated with chemotherapy. Protein Technology segment contains the financial information of the activities, including BioTherapeutics, Bioseparation and Prion Capture/Pathogen Removal.

Officers and directors

Simon Geoffrey Best Independent Chairman of the Board
Age: 58
Pierre Laurin Ph.D. President, Chief Executive Officer, Director
Age: 75
Bruce Pritchard Chief Financial Officer, Chief Operating Officer
Steve J. Burton Chief Executive Officer of ProMetic BioSciences Ltd.
Age: 62
Patrick Sartore General Counsel, Corporate Secretary
John Moran M.D. Chief Medical Officer, Director
Age: 69
Dwun-Hou Chen Ph.D. Senior Vice President, Product and Asia Pacific Development of ProMetic BioTherapeutics, Inc.
Stefan Clulow Director
Age: 44
Charles Kenworthy Director
Age: 57
Bruce J. Wendel Director
Age: 61